Literature DB >> 10887339

Production of fibrogenic cytokines by cord blood-derived cultured human mast cells.

N Kanbe1, M Kurosawa, H Nagata, T Yamashita, F Kurimoto, Y Miyachi.   

Abstract

BACKGROUND: Mast cells are a potential source of cytokines, but their contribution to nonallergic inflammatory conditions, such as fibrosis, remains unclear.
OBJECTIVE: We investigated whether cord blood-derived cultured human mast cells could produce fibrogenic cytokines by IgE-mediated activation.
METHODS: Mast cells were obtained from human cord blood mononuclear cells by culture with stem cell factor and IL-6. The mast cells were incubated with human myeloma IgE and were activated with anti-IgE. The expression of messenger RNA for fibrogenic cytokines was examined by the reverse-transcription polymerase chain reaction, and cytokine protein was assayed by enzyme-linked immunosorbent assay, or bioassay.
RESULTS: Cultured human mast cells constitutively expressed mRNA for transforming growth factor-beta(1), and its expression was not increased by anti-IgE stimulation. The cells released this factor into the culture medium spontaneously, which showed bioactivity after heat treatment. The mast cells also expressed mRNA for platelet-derived growth factor A, which was enhanced with a peak at 3 hours by stimulation with anti-IgE. Conditioned medium from nonactivated mast cells did not contain basic fibroblast growth factor, but this cytokine was released into the medium in a time-dependent manner after stimulation with anti-IgE.
CONCLUSION: Human mast cells activated by IgE-mediated stimulation show production of fibrogenic cytokines that varies depending on the cytokine, which suggests possible involvement of mast cell cytokines in the development of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887339     DOI: 10.1067/mai.2000.106777

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures.

Authors:  Michael J Monument; David A Hart; A Dean Befus; Paul T Salo; Mei Zhang; Kevin A Hildebrand
Journal:  Inflamm Res       Date:  2011-12-16       Impact factor: 4.575

2.  Chymase-positive mast cells in small sized adenocarcinoma of the lung.

Authors:  Manabu Nagata; Noriharu Shijubo; Andrew F Walls; Shingo Ichimiya; Shosaku Abe; Noriyuki Sato
Journal:  Virchows Arch       Date:  2003-06-25       Impact factor: 4.064

Review 3.  Late-phase urticaria Update.

Authors:  Naotomo Kambe; Aki Kitao; Chikako Nishigori; Yoshiki Miyachi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

Review 4.  Mast cells in the pathogenesis of fibrosis.

Authors:  Barry L Gruber
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

5.  The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.

Authors:  Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 6.  Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.

Authors:  Stephanie A Legere; Ian D Haidl; Jean-François Légaré; Jean S Marshall
Journal:  Front Immunol       Date:  2019-03-28       Impact factor: 7.561

Review 7.  C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases.

Authors:  Weina Wang; Liyan Shui; Yanning Liu; Min Zheng
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

Review 8.  Research Progress of Myocardial Fibrosis and Atrial Fibrillation.

Authors:  Guangling Li; Jing Yang; Demei Zhang; Xiaomei Wang; Jingjing Han; Xueya Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-25

Review 9.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

Review 10.  Immune cells and angiogenesis.

Authors:  Domenico Ribatti; Enrico Crivellato
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.